Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Zingsem

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Vox Sanguinis|November 25, 2003
First comparison of productivity and citrate donor load between the Trima version 4 (dual-stage filler) and the Trima Accel (single-stage filler) in the same donorsJ Ringwald, J Zingsem, R Zimmermann, et al.
Vox Sanguinis|January 1, 1994
A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD immunisation after RhD-incompatible single donor platelet transfusionT Zeiler, G Wittmann, J Zingsem, et al.
Transfusion|July 21, 1999
Antibodies to private and public HLA class I epitopes in platelet recipientsR Zimmermann, G Wittmann, J Zingsem, et al.
Transfusion|September 30, 1999
The influence of automated plateletpheresis on systemic levels of hematopoietic growth factorsV Weisbach, H Friedlein, A Glaser, et al.
Transfusion|March 29, 2001
Comparison of a new WBC-reduction system and the standard plateletpheresis protocol in the same donorsJ Zingsem, R Zimmermann, V Weisbach, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1996
[Expanded serologic infection testing of autologous blood donors: a report of experiences]R Zimmermann, V Weisbach, G Wittmann, et al.
Transfusion|March 10, 2001
The variability of compensatory erythropoiesis in repeated autologous blood donationV Weisbach, C Corbière, E Strasser, et al.
Infusionstherapie Und Transfusionsmedizin|April 1, 1994
[18 months experience with a new single needle cytapheresis system (Fresenius AS 104 SN)]T Zeiler, J Zingsem, V Weisbach, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
[Anti-M after transfusion as an indication of a genetic variant of the MN locus]H G Heuft, V Weisbach, T Zeiler, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1994
[MLC reactivity demonstrates transfusion-induced immunosuppression]J Zingsem, V Weisbach, T Zeiler, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Vox Sanguinis|November 25, 2003
First comparison of productivity and citrate donor load between the Trima version 4 (dual-stage filler) and the Trima Accel (single-stage filler) in the same donorsJ Ringwald, J Zingsem, R Zimmermann, et al.
Vox Sanguinis|January 1, 1994
A dose of 100 IU intravenous anti-D gammaglobulin is effective for the prevention of RhD immunisation after RhD-incompatible single donor platelet transfusionT Zeiler, G Wittmann, J Zingsem, et al.
Transfusion|July 21, 1999
Antibodies to private and public HLA class I epitopes in platelet recipientsR Zimmermann, G Wittmann, J Zingsem, et al.
Transfusion|September 30, 1999
The influence of automated plateletpheresis on systemic levels of hematopoietic growth factorsV Weisbach, H Friedlein, A Glaser, et al.
Transfusion|March 29, 2001
Comparison of a new WBC-reduction system and the standard plateletpheresis protocol in the same donorsJ Zingsem, R Zimmermann, V Weisbach, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1996
[Expanded serologic infection testing of autologous blood donors: a report of experiences]R Zimmermann, V Weisbach, G Wittmann, et al.
Transfusion|March 10, 2001
The variability of compensatory erythropoiesis in repeated autologous blood donationV Weisbach, C Corbière, E Strasser, et al.
Infusionstherapie Und Transfusionsmedizin|April 1, 1994
[18 months experience with a new single needle cytapheresis system (Fresenius AS 104 SN)]T Zeiler, J Zingsem, V Weisbach, et al.
Beitrage Zur Infusionstherapie = Contributions to Infusion Therapy|January 1, 1992
[Anti-M after transfusion as an indication of a genetic variant of the MN locus]H G Heuft, V Weisbach, T Zeiler, et al.
Beitrage Zur Infusionstherapie Und Transfusionsmedizin = Contributions to Infusion Therapy and Transfusion Medicine|January 1, 1994
[MLC reactivity demonstrates transfusion-induced immunosuppression]J Zingsem, V Weisbach, T Zeiler, et al.
Pageof 10